Clinical Trials Browser

Phase 1/2 × NSCLC × Other solid neoplasm × Clear all

NCT05332574 2022-08-05

A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor

Phase 1/2 Unknown

Other solid neoplasmThoracic

NSCLC